Yingying Guo-Avrutin, Ph.D.

Executive Director
Eli Lilly and Company

Poster(s):

• (T0930-02-07) Evaluation of the Effect of Food and Gastric pH Change on the Pharmacokinetics and Safety of Imlunestrant in Healthy Volunteers
  Tuesday, October 22, 2024

  9:30 AM – 10:30 AM MT

• (W0930-02-10) Evaluation of the Disposition and Absolute Bioavailability of Imlunestrant in Healthy Volunteers
  Wednesday, October 23, 2024

  9:30 AM – 10:30 AM MT